Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atenolol vs Losartan in Marfan Syndrome
NCT00429364Phase 3Completed
- Sponsor
- Elevance Health
- Start
- Jan 2007
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of losartan in Marfan syndrome (MFS), sponsored by Elevance Health. Started Jan 2007; status: completed.
02
Drugs
losartan
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on NCT00429364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429364.